Paclitaxel-d5 (CAS No 1129540-33-5) is a deuterated analog of paclitaxel used in biomedical research primarily to study the pharmacokinetics and metabolism of the parent compound Originating from the bark of the Pacific yew tree paclitaxel acts by stabilizing microtubules and inhibiting their depolymerization thus blocking cell division and inducing apoptosis in cancer cells Its mechanism of action specifically affects the tubulin-microtubule pathway Paclitaxel-d5 exhibits activity in the nanomolar to low micromolar range in vitro making it a valuable tool in cell models and animal studies aimed at understanding cancer cell sensitivity or resistance to taxanes It is frequently used in drug screening assays to evaluate potential therapeutic efficacy or investigate drug interactions Experimental concentrations typically depend on the specific research design